Importance Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are related
inflammatory disorders occurring in persons aged 50 years and older. Diagnostic and …

Polymyalgia rheumatica is an inflammatory disease that affects the shoulder, the pelvic
girdles, and the neck, usually in individuals older than 50 years. Increases in acute phase …

Key Clinical Points Giant-Cell Arteritis and Polymyalgia Rheumatica The immune-mediated
diseases giant-cell arteritis and polymyalgia rheumatica occur in patients 50 years of age or …

Background Biologics are used for the treatment of rheumatoid arthritis and many other
conditions. While the efficacy of biologics has been established, there is uncertainty …

Polymyalgia rheumatica (PMR) is the most common inflammatory rheumatic disease
affecting people older than 50 years and is 2–3 times more common in women. The most …

The fields of giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) have advanced
rapidly, resulting in a new understanding of these diseases. Fast-track strategies and …

Background Polymyalgia rheumatica is the second most common inflammatory rheumatic
disease of people> 50 years. Glucocorticoid therapy is highly effective, but many patients …

Polymyalgia rheumatica and giant-cell arteritis are closely related disorders that affect
people of middle age and older. They frequently occur together. Both are syndromes of …

Background—In giant cell arteritis (GCA), vasculitic damage of the aorta and its branches is
combined with a syndrome of intense systemic inflammation. Therapeutically …

Abstract On August 24, 1998, Remicade®(infliximab), the first tumor necrosis factor-α (TNF)
inhibitor, received its initial marketing approval from the US Food and Drug Administration …